Healthcare Asia Pharma Awards 2024: Bushu Pharmaceuticals
Bushu Pharmaceuticals' ESG Promotion Manager, Yasuko Watanabe, discusses the company's commitment to sustainability in healthcare, including CO2 reduction initiatives and wastewater treatment upgrades.
Learn how they clinched the ESG Program of the Year - Japan and Sustainability Initiative of the Year - Japan accolades at the Healthcare Asia Pharma Awards 2024 by clicking here.
Commentary
Public health at scale: Lessons from implementing AI across government health programmes
Clearing the air: Why Singapore's haze problem is an eldercare crisis in plain sight
Beyond ChatGPT: The rise of multimodal AI assistants in clinical settings